Skip to content

Multimodal Gait Training With and Without Rhythmic Auditory Stimulation in Chronic Stroke Patients

Effects of Multimodal Gait Training With and Without Rhythmic Auditory Stimulation on Coordination, Gait and Risk of Fall in Chronic Stroke Patients

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06696950
Enrollment
42
Registered
2024-11-20
Start date
2024-01-10
Completion date
2024-12-05
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke Patients

Keywords

Chronic Stroke, Gate Training, Multimodal, Rhythmic auditory stimulation

Brief summary

The primary goal of this randomized clinical trial is to investigate the efficacy of multimodal gait training, with and without rhythmic auditory stimulation, in improving gait, coordination and reducing fall risk in individuals with chronic stroke This clinical trial features two distinct groups 42 participants were randomly divided into two groups of 21. Group A will receive Multimodal gait training along with rhythmic auditory stimulation while Group B will receive only multimodal gait training Participants will: * Take 12 sessions of the MMGT program over six weeks * With each session lasting 45 minutes, including 10-minute rest breaks.

Interventions

OTHERMutimodal gait training includes unilateral step training, inclined treadmill training, over ground training with rhythmic auditory stimulation

Unilateral step training, inclined treadmill training, over ground training, repetitive isochronous pulses via metronome

OTHERMultimodal gait training

Unilateral step training, inclined treadmill training, over ground training,

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Participants of age between 45 and 70 year * Participants of both genders were included. * Participants who were able to walk independently indoors without walking aid * Participants were included if they had lower limb motor impairment (Fugl-Meyer Assessment lower extremity (FMLE) score less than score less than 34 * Participants with stroke lasting longer than six months * Participants with Mini-Mental Status Examination score 24 or more than 24 * Participants with the capability to keep in sitting position for 30 minutes * Participants with the history of fall in the past year * Participants with no visual or auditory impairments that would interfere with the training

Exclusion criteria

* Participants with respiratory problems. * Participants with any orthopedic condition. * Participants with aphasia that impeded communication. * Participants with have severe cardiac disease. * Participants with resistant hypertension despite use of medication (average systolic blood pressure ≥ 140 mmHg or average diastolic blood pressure ≥ 90 mmHg measured over 7 days) * Participants with presence of non-healing ulcers in the lower limbs, and osteoporosis

Design outcomes

Primary

MeasureTime frameDescription
LOWER EXTREMITY MOTOR COORDINATON TEST (LEMCOT)6 weeksThe Lower Extremity Motor Coordination test (LEMCOT) is a clinically useful performance-based test to assess coordination improvements of lower limb in post-stroke individuals
Dynamic gait index (DGI)6 weeksThe dynamic gait index is a comprehensive clinical assessment performance based tool used designed to evaluate gait-related task such as dynamic balance, gait and risk of fall in older adults with various neurological conditions
Fall Efficacy Scale-International (FES-I)6 weeksFall efficacy scale-international (FES- I) is a standardized, short and easy to administer tool evaluates fear of falling and measures concerns about falling

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026